NCT05520528

Brief Summary

The purpose of the study is to examine the impact of group participation on adults with aphasia. Participants will complete a standard pre-and post-assessment of language abilities (speech, comprehension, reading, and/or writing). Then participants will attend 90-minute weekly reading group sessions during an academic semester.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Sep 2022Dec 2026

First Submitted

Initial submission to the registry

August 19, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 30, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

September 6, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

July 3, 2025

Status Verified

July 1, 2025

Enrollment Period

3.9 years

First QC Date

August 19, 2022

Last Update Submit

July 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reading Comprehension Battery for Aphasia-2 (RCBA-2; LaPointe & Horner, 1998) Scores

    To determine if group participation improves intervention-specific language skills in reading comprehension by comparing baseline score to 1-week post-intervention score

    1-week after intervention

Secondary Outcomes (5)

  • Communication Confidence Rating Scale for Aphasia (CCRSA; Babbitt & Cherney, 2010)

    1-week post-intervention

  • Discourse Production Task

    1-week post-intervention

  • Patient Reported Outcomes Measurement Information System (PROMIS)

    1-week post-intervention

  • Gray Oral Reading Test (GORT; Wiederholt & Bryant, 2012)

    1-week post-intervention

  • Writing of Untrained Control Words (non-standardized).

    1-week post-intervention

Study Arms (1)

Reading Group

EXPERIMENTAL

All participants in this group will receive language intervention within weekly group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia.

Behavioral: Language intervention with group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia

Interventions

The participants will read through a designated book incrementally across multiple weeks at home and complete reading, writing, and discussion related to weekly readings in a group setting.

Reading Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Pre-morbid proficient speaker of English
  • Diagnosis of adult-onset aphasia
  • Vision and hearing sufficient to complete assessments

You may not qualify if:

  • No history of childhood speech or language difficulties
  • No history of major psychiatric illness, cognitive impairment, or neurological disorders such as seizures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UAM CHP Speech-Language and Hearing Clinic

Little Rock, Arkansas, 72204, United States

Location

MeSH Terms

Conditions

AphasiaStrokeLanguage Disorders

Condition Hierarchy (Ancestors)

Speech DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Dana Moser, Ph.D

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2022

First Posted

August 30, 2022

Study Start

September 6, 2022

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

July 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations